1. Home
  2. CDT vs CTNT Comparison

CDT vs CTNT Comparison

Compare CDT & CTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • CTNT
  • Stock Information
  • Founded
  • CDT 2019
  • CTNT 2016
  • Country
  • CDT United States
  • CTNT United States
  • Employees
  • CDT 7
  • CTNT N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • CTNT
  • Sector
  • CDT Health Care
  • CTNT
  • Exchange
  • CDT Nasdaq
  • CTNT Nasdaq
  • Market Cap
  • CDT 9.0M
  • CTNT 9.4M
  • IPO Year
  • CDT N/A
  • CTNT 2023
  • Fundamental
  • Price
  • CDT $0.07
  • CTNT $3.15
  • Analyst Decision
  • CDT
  • CTNT Hold
  • Analyst Count
  • CDT 0
  • CTNT 1
  • Target Price
  • CDT N/A
  • CTNT N/A
  • AVG Volume (30 Days)
  • CDT 16.2M
  • CTNT 6.1M
  • Earning Date
  • CDT 02-14-2025
  • CTNT 11-13-2024
  • Dividend Yield
  • CDT N/A
  • CTNT N/A
  • EPS Growth
  • CDT N/A
  • CTNT N/A
  • EPS
  • CDT N/A
  • CTNT N/A
  • Revenue
  • CDT N/A
  • CTNT $7,703,113.00
  • Revenue This Year
  • CDT N/A
  • CTNT N/A
  • Revenue Next Year
  • CDT N/A
  • CTNT N/A
  • P/E Ratio
  • CDT N/A
  • CTNT N/A
  • Revenue Growth
  • CDT N/A
  • CTNT N/A
  • 52 Week Low
  • CDT $0.06
  • CTNT $1.70
  • 52 Week High
  • CDT $5.44
  • CTNT $236.16
  • Technical
  • Relative Strength Index (RSI)
  • CDT 40.15
  • CTNT 50.66
  • Support Level
  • CDT $0.08
  • CTNT $2.83
  • Resistance Level
  • CDT $0.09
  • CTNT $4.56
  • Average True Range (ATR)
  • CDT 0.01
  • CTNT 0.92
  • MACD
  • CDT -0.00
  • CTNT 0.00
  • Stochastic Oscillator
  • CDT 27.18
  • CTNT 5.81

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the China market. The parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers' official distribution systems. The company purchases automobiles, luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to customers, including both U.S. and PRC parallel-import car dealers. The company derives profits from the price difference between buying and selling prices for parallel-import vehicles.

Share on Social Networks: